MANY species of venomous snakes have a high resistance to their own venoms and to those from other individuals of the same species and other species1–4. The resistance is not absolute but it increases as the size of the snake increases, and varies also with the type of venom. Blood plasma or sera of several species neutralise the venom of the same species and of other species both in vivo and in vitro5–11. As Clark and Voris10 reported, the whole serum of the eastern diamondback rattlesnake (Crotalus adamanteus) neutralises lethal doses of C. adamanteus venom in mice and the protective capacity of the serum is associated with the serum albumin fraction. Mixtures of C. adamanteus serum and Venom show no evidence of precipitation, such as occurs when serum from animals hyperimmunised with C. adamanteus venom is mixed with C. adamanteus venom. The nature of the factor(s) in rattlesnake plasma, which neutralise rattlesnake venom toxins, and the mechanism of neutralisation are unknown. We have found that both western and eastern diamondback rattlesnake (C. atrox and C. adamanteus) blood plasma contain antivenom factor(s) and have a neutralisation capacity (NC), not only for C. atrox venom but also other rattlesnake venoms. The antivenom activity of C. atrox plasma is sufficiently potent, compared with commercial immunoglobulin antivenin, to be potentially useful in the management of snakebite.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Noguchi, H., The Action of Snake Venom upon Cold-blooded Animals, Pub. 12, 1–16 (Carnegie Institution of Washington, Washington, D. C., 1909).
Nichol, A. A., Douglas, V., and Peck, L., Copeia, 211–213 (1933).
Keegan, H., and Andrews, T. F., Copeia, 251–254 (1942).
Swanson, P. L., Copeia, 242–249 (1946).
Kellaway, C. H., Bull. Johns Hopkins Hosp., 60, 159–161 (1937).
Rosenfeld, S., and Glass, S., Am. J. med. Sci., 199, 482–486 (1940).
Peterson, H., and Koivastik, T., Z. Immunitaets Forsch. Allergic Klin. Immun., 102, 324–329 (1942).
Philpot, V. B., Jr., Herpetologica, 10, 158–160 (1954).
Deoras, P. J., and Mhasalkar, V. B., Toxicon, 1, 89–90 (1963).
Clark, W. C., and Voris, H. K., Science, 164, 1402–1404 (1969).
Omori-Satoh, T., Sadahiro, S., Otlsaka, A., and Murata, R., Biochim. biophys. Acta, 285, 414–426 (1972).
Phisalix, C., and Bertrand, G., C.r. hebd. Séanc. Soc. Biol., 2, 751–752 (1890).
Gornall, A. G., Bardawill, C. G. J., and David, M. M., J. biol. Chem., 177, 751–754 (1949).
Kärber, G., Arch. exp. Path. Pharmak., 162, 480–483 (1931).
Reed, L. J., and Muench, H., Am. J. Hygiene, 27, 493–497 (1938).
Thompson, W. R., Bact. Rev., 11, 115–145 (1947).
Glenn, J. L., Straight, R., and Snyder, C. C., Toxicon, 10, 575–579 (1972).
Glenn, J. L., Straight, R., and Snyder, C. C., Am. J. vet. Res., 33, 1901–1903 (1972).
About this article
Cite this article
STRAIGHT, R., GLENN, J. & SNYDER, C. Antivenom activity of rattlesnake blood plasma. Nature 261, 259–260 (1976). https://doi.org/10.1038/261259a0
Communications in Mathematical Physics (1980)